Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Mar;53(3):813-8.
doi: 10.1172/JCI107620.

Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid

Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid

E J Goetzl et al. J Clin Invest. 1974 Mar.

Abstract

Incubation of human leukocytes with ascorbic acid at neutral pH and at concentrations 10-50 times that of normal blood levels augmented both the in vitro random migration and chemotaxis of the cells by 100-300% without influencing their phagocytic capacity. Enhancement of mobility by ascorbate was evident for isolated neutrophils, eosinophils, and mono-nuclear leukocytes and was independent of the specific chemotactic stimulus. Stimulation by ascorbate of the hexose monophosphate shunt of adherent neutrophils and augmentation by ascorbate of neutrophil mobility had comparable dose-response relationships, could be reversed by washing the cells, and were both suppressed by preincubation of the neutrophils with 6-aminonicotinamide, but not with the neutrophil-immobilizing factor. Glutathione, the proposed intermediate for ascorbate action, similarly stimulated hexose monophosphate shunt activity and enhanced migration. The enhancement in vitro of leukocyte mobility by ascorbate at concentrations found in some normal tissues, therefore, appears to be dependent upon stimulation of the leukocyte hexose monophosphate shunt.

PubMed Disclaimer

References

    1. J Clin Invest. 1974 Feb;53(2):591-9 - PubMed
    1. J Exp Med. 1962 Mar 1;115:453-66 - PubMed
    1. Scand J Clin Lab Invest Suppl. 1968;97:31-50 - PubMed
    1. J Immunol. 1969 Jan;102(1):93-9 - PubMed
    1. Immunology. 1970 Jun;18(6):955-9 - PubMed